Thor Danielle C, Patel Krut, Singh Monisha
Internal Medicine, Jefferson Health New Jersey, Stratford, USA.
Cureus. 2024 Jun 25;16(6):e63101. doi: 10.7759/cureus.63101. eCollection 2024 Jun.
The growth of the transgender and/or gender diverse (TGD) community has created an increased demand for comprehensive and evidence-based gender-affirming care, especially when providing a hormone-based regimen. Although there are known risks of adverse events from receiving exogenous hormone replacement therapy, many of these risks are typically attributed to members of the TGD community receiving estrogen-based therapy. In this report, a case of a subsegmental pulmonary embolism in a male patient assigned female at birth who was actively receiving testosterone-based, female-to-male gender-affirming care is detailed. In doing so, attention is drawn to a potential complication of this approach, thereby empowering clinicians and patients alike to be cognizant of such risks while still pursuing this otherwise pivotal and necessary care.
跨性别和/或性别多元（TGD）群体的壮大，使得对全面且基于证据的性别肯定治疗的需求不断增加，尤其是在提供基于激素的治疗方案时。尽管接受外源性激素替代疗法存在已知的不良事件风险，但其中许多风险通常被认为是接受雌激素治疗的TGD群体成员所面临的。在本报告中，详细介绍了一名出生时被指定为女性的男性患者在积极接受基于睾酮的女变男性别肯定治疗过程中发生亚段肺栓塞的病例。通过这样做，人们注意到了这种治疗方法的一种潜在并发症，从而使临床医生和患者都能在继续寻求这种关键且必要的治疗的同时，意识到此类风险。
